Company / Goodwill
Supernus Pharmaceuticals, Inc. Goodwill History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$124.9M
FY2025
5-year range
$117.0M / $124.9M
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
#34 of 74
Health Care
What the data says
At $125M, Supernus Pharmaceuticals, Inc.'s goodwill ranks #34 of 74 in the Health Care sector. Improved from $117M to $125M over the past 2 years.
Based on SEC 10-K filings.
$125M in FY2025 with a 5-year CAGR of +9.9%.
Improved from $117M to $125M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +2.2%
- 5-Year CAGR
- +9.9%
- 10-Year CAGR
- -
Sector benchmark
#34 of 74 in Health CareTop 46% of 74This company $124.9M Sector average $4.0B
▼
-96.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.9%, indicating consistent growth.
- In FY2025, goodwill increased 6.7% year-over-year.
- Ranks #34 out of 74 companies in the Health Care sector.
- Lowest goodwill in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $124.9M | +6.7% |
| FY2024 | $117.0M | +0.0% |
| FY2023 | $117.0M | +0.0% |
| FY2022 | $117.0M | -0.4% |
| FY2021 | $117.5M | +50.8% |
| FY2020 | $77.9M | - |
| FY2019 | $0 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026